Table 3 Reporting of harm in reports of randomized controlled trials assessing stent treatment for coronary diseases by type of stent
| Â | All reports | Drug-eluting stent | Polymer-coating stent | Bare metal stent |
|---|---|---|---|---|
| Â | N = 132 | N = 64 | N = 19 | N = 41 |
| Â | N (%) | N (%) | N (%) | N (%) |
Nature of harm | Â | Â | Â | Â |
   - Reporting with numerical data per trial arm when considering |  |  |  |  |
- All adverse events | 115 (87) | 52 (81) | 15 (79) | 39 (95) |
- Events other than MAC(C)E1 | 66 (50) | 32 (50) | 8 (42) | 20 (49) |
Harm severity | Â | Â | Â | Â |
   - Reporting with numerical data per trial arm when considering |  |  |  |  |
- All adverse events | 114 (86) | 52 (81) | 15 (79) | 39 (95) |
- Events other than MAC(C)E1 | 17 (13) | Â | Â | Â |
Relation of harm to treatment | 4 (3) | 2 (3) | 1 (5) | 1 (2) |
Procedural complications | 30 (23) | 9 (14) | 3 (16) | 14 (34) |